Clincosm LogoSign in Get a demo

Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00018837
Collaborator
(none)
1
Location
35
Duration (Months)

Study Details

Study Description

Brief Summary

The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Community Re-Entry Program: What is Schizophrenia
 N/A

Study Design

Study Type:
Interventional
Intervention Model:
Parallel Assignment
Official Title:
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
Study Start Date :
Apr 1, 1998
Study Completion Date :
Mar 1, 2001

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1. Age 18-65 years of age.

    2. DSM IV diagnosis of schizophrenia or schizoaffective disorder.

    3. Competent to give informed consent.

    4. Previously participated in "Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome" Principal Investigator. Donna Wirshing, M.D.

    Exclusion Criteria:

    1. Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent.

    2. History of substantial substance dependence 6 months prior to the study.

    3. Patients at high risk of suicide or other directed violence.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 VA Greater Los Angeles Healthcare System Los Angeles California United States 90073

    Sponsors and Collaborators

    • US Department of Veterans Affairs

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00018837
    Other Study ID Numbers:
    • MHBS-010-98S
    First Posted:
    Jul 5, 2001
    Last Update Posted:
    Jan 21, 2009
    Last Verified:
    Dec 1, 2004
    Additional relevant MeSH terms:
    Schizophrenia

    Study Results

    No Results Posted as of Jan 21, 2009